Remove 2010 Remove Cannabis Remove Data Remove Research and Development
article thumbnail

DEA finally ends fed monopoly on schwaggy research-grade cannabis

SpeedWeed

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. In other words, the feds are ending their monopoly on cannabis grown for scientific purposes. cannabis researchers.

DEA 52
article thumbnail

Are Cannabis Users 22% More Likely to Need Emergency Care?

Veriheal

Cannabis’ impact on health is a subject area rife with misunderstanding and controversy. Recently, a study found that cannabis users are more likely to end up needing emergency care, claiming that “cannabis use is not as benign and safe as some might think.” Cannabis Consumers at the Hospital .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Akerna Releases 2021 Cannabis Industry Mid-Year Review

Cannabis Law Report

Akerna (Nasdaq: KERN ), an enterprise software, leading compliance technology provider, and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®) today announced the release of its second annual mid-year review. You can access the report here. About Akerna.

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94
article thumbnail

Scientists Rank Most Dangerous Drugs

CannaMD

In 2010, a group of scientists from the United Kingdom’s Independent Scientific Committee on Drugs , including two invited specialists, met to rank the harm levels of 20 drugs. hydroxybutyric acid [GHB], methadone, and butane), whereas economic cost contributed heavily to alcohol, heroin, tobacco, and cannabis. Translation?

article thumbnail

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid. He was also listed in “Best Doctors in America” in 2007, 2009, and 2010. ” About Ehave, Inc.

article thumbnail

Cannabis – The study that blew my mind

Cannabis Law Report

I was a young cannabis research student on my first trip overseas to an international research conference. Events like these afford us a glimpse into the future of research and medicine in this field. None of the patients developed acute GVHD while consuming CBD (ie, before day 30). Implications.